聚焦康复的社区支持以避免再入院并改善卒中后参与度的随机对照临床试验统计分析计划
ReCAPS试验旨在检验为期12周、包含个性化目标设定与配套教育/激励电子信息的自我管理干预的效果。主要结局为随机化后90天内自我报告的非计划医院就诊(急诊科/入院)。本文介绍该试验的统计分析计划,样本量890例,以80%把握度和5%显著性水平(双侧)检测报告非计划医院就诊/入院参与者比例绝对降低10%。
要点
- 样本量890例,计算依据为检测非计划医院就诊/入院参与者比例绝对降低10%,80%把握度、5%显著性水平(双侧)。
- 主要结局分析基于意向性治疗,采用校正分层变量的逻辑回归;P值≤0.05表示统计学显著。
- 次要结局采用适当的回归模型评估;独立的数据安全与监查委员会定期审查试验进展与安全性。
核心结论
- 该统计分析计划确保试验结局报告的透明性。
- ReCAPS试验将提供关于卒中后数字健康支持包有效性的新证据。
研究设计与样本
- ReCAPS试验为随机对照临床试验,参与者按1:1随机分组,采用可变区组大小,并按年龄和基线残疾水平进行分层平衡。
- 样本量为890例参与者,计算依据为检测报告非计划医院就诊/入院参与者比例绝对降低10%,80%把握度、5%显著性水平(双侧)。
- 招募将于2023年12月资金用完时结束,届时将采用实际达到的样本量。
- 主要结局分析基于意向性治疗,采用校正分层变量的逻辑回归确定干预效果;次要结局采用适当的回归模型评估。
- P值≤0.05表示统计学显著;独立的数据安全与监查委员会定期审查试验进展与安全性。
关键数值与推荐
- 主要结局为随机化后90天内自我报告的非计划医院就诊(急诊科/入院)。
- 样本量890例,计算依据为检测报告非计划医院就诊/入院参与者比例绝对降低10%,80%把握度、5%显著性水平(双侧)。
- 主要结局分析基于意向性治疗,采用校正分层变量的逻辑回归;P值≤0.05表示统计学显著。
- 次要结局采用适当的回归模型评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unplanned hospital presentations may occur post-stroke due to inadequate preparation for transitioning from hospital to home. The Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS) trial was designed to test the effectiveness of receiving a 12-week, self-management intervention, comprising personalised goal setting with a clinician and aligned educational/motivational electronic messages. Primary outcome is as follows: self-reported unplanned hospital presentations (emergency department/admission) within 90-day post-randomisation. We present the statistical analysis plan for this trial. METHODS/DESIGN: Participants are randomised 1:1 in variable block sizes, with stratification balancing by age and level of baseline disability. The sample size was 890 participants, calculated to detect a 10% absolute reduction in the proportion of participants reporting unplanned hospital presentations/admissions, with 80% power and 5% significance level (two sided). Recruitment will end in December 2023 when funding is expended, and the sample size achieved will be used. Logistic regression, adjusted for the stratification variables, will be used to determine the effectiveness of the intervention on the primary outcome. Secondary outcomes will be evaluated using appropriate regression models. The primary outcome analysis will be based on intention to treat. A p-value ≤ 0.05 will indicate statistical significance. An independent Data Safety and Monitoring Committee has routinely reviewed the progress and safety of the trial. CONCLUSIONS: This statistical analysis plan ensures transparency in reporting the trial outcomes. ReCAPS trial will provide novel evidence on the effectiveness of a digital health support package post-stroke. TRIAL REGISTRATION: ClinicalTrials.gov ACTRN12618001468213. Registered on August 31, 2018. SAP version 1.13 (October 12 2023) Protocol version 1.12 (October 12, 2022) SAP revisions Nil.
引用
- Kilkenny MF, Olaiya MT, Cameron J, et al. Statistical analysis plan for the Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke randomised controlled clinical trial. Trials. 2024. PMID: 38263172. doi:10.1186/s13063-023-07864-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。